Iván Murrieta-Álvarez, MD^1,2*, Montserrat Rivera-Álvarez, MD^2*, Gilberto David Elias-de-la-Cruz, MD^1*, Luisa Fernanda Sánchez-Valledor, MD^3*, Carmina Alejandra Córdova-Ramírez^2*, Yahveth Cantero-Fortiz, MD^1,3*, Andrés A. León-Peña, MD^1,4*, Martin Ojeda-Laguna, BSc^1*, José Manuel Priesca-Marin, MD^1*, Guillermo J. Ruiz-Delgado, MD, FACP^1,2* and Guillermo J. Ruiz-Arguelles, FRCP, MACP^2,5,6

¹Centro de Hematología y Medicina Interna, Clínica Ruiz, Puebla, Mexico
²Universidad Popular Autónoma del Estado de Puebla, Puebla, Mexico
³Universidad de las Américas Puebla, San Pedro Cholula, Mexico
⁴Benemérita Universidad Autónoma de Puebla, Puebla, Mexico
⁵Laboratorios Ruiz, Puebla, Mexico
⁶Centro De Hematologia Medicina Interna, Puebla, Pue, Mexico

Mahmoud R. Gaballa, MD¹, Taha Al-Juhaishi, MD¹, Qaiser Bashir, MD², Samer A. Srour, MD, MS², Neeraj Saini, MD², Jeremy Ramdial, MD³, Yago Nieto, MD⁴, Regan Murphy, PA-C^3*, Hans C. Lee, MD⁵, Krina K. Patel, M.D.⁶, Partow Kebriaei, MD³, Sheeba K. Thomas, MD⁵, Donna M. Weber, MD⁵, Robert Z. Orlowski, MD, PhD⁷, Richard E. Champlin, MD³ and Muzaffar H. Qazilbash, MD¹

¹Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX
²Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Department of Stem Cell Transplantation and Cellular Therapy, UT M.D. Anderson Cancer Ctr., Houston, TX
⁵Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁶Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁷Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX

Vishal K Gupta, MD¹, Areej El-Jawahri, MD², Murali Janakiram, MD³, Mariam H Johnson, MPH^4*, Janice Weinberg, PhD^5*, Courtney B Goodrich^5*, Grigori Okoev, MD, PhD³ and John Mark Sloan, MD¹

¹Boston University Medical Center, Boston, MA
²Massachusetts General Hospital / Harvard Medical School, Allston, MA
³Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN
⁴Center for International Bone and Marrow Transplant Research, Milwaukee, WI
⁵Department of Biostatistics, Boston University School of Public Health, Boston, MA

Yin Jie Koh^1*, Louis-Pierre Girard, MBChB^2*, Hian Li Esther Hian Li Chan, MRCP, FRCPATH^3*, Joanne Shu Xian Lee, MBBS, MRCP^4,5*, Yen-Lin Chee, MBChB, FRCPath, PhD³, Anand Jeyasekharan^6*, Sanjay de Mel, MRCP(UK) FRCPath^7*, Cinnie Yentia Soekojo, MD⁸, Xin Liu^9*, Liang Piu Koh, MBBS, MRCP^1*, Michelle Poon, MBBS, MRCP, FRCPATH^10* and Miny Samuel^11*

¹Department of Haematology­-Oncology, National University Cancer Institute, National University Health System, Singapore, Singapore
²Aberdeen Royal Infirmary, Aberdeen, United Kingdom
³Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore, Singapore
⁴Department of Haematology-Oncology, National University Cancer Institute of Singapore (NCIS), Singapore, Singapore
⁵National University Hospital, Singapore, Singapore
⁶Department of Haematology-Oncology, National University Cancer Institute of Singapore, Singapore, Singapore
⁷Department of Haematology Oncology, National University Cancer Institute, National University Health System, Singapore, Singapore
⁸Department of Hematology-Oncology, National University Cancer Institute, National University Health System, Singapore, Singapore
⁹Department of Haematology-Oncology, National University Hospital, National University Cancer Institute, Singapore (NCIS), Singapore, Singapore
¹⁰Department of Haematology-Oncology, National University Cancer Institute, National University Health System, Singapore, Singapore
¹¹Research Support Unit, National University of Singapore, Singapore, Singapore

Edvan De Queiroz Crusoe, MD, PhD^1,2, Marco Aurelio Salvino, MD, PhD^3,4, Sarah Queiroz Silva, MD^5*, Herbert Henrique de Melo Santos, MD^6*, Allan de souza Santos, BS^7*, Alessandro de M. Almeida, MD^8,9, Lucas de Oliveira Vieira, MD^10*, Cleverson Alves Fonseca, Pham^11*, Larissa Ferreira Lucas, MD^12*, Joanna Leal, MD^13*, Mariane Melo Santos, BS, MsC^14*, Juliana Andrade Santos, MD^15*, Elisangela Adorno, Pham, PhD^16*, Vania T. M. Hungria, MD, PhD¹⁷ and Maria da Gloria B. Arruda, MD, PhD^4,18*

¹Rua Dra Doutro Vianna S/n, Universidade Federal da Bahia- Hospital Universitario, Salvador, Brazil
²Hematology department- D'or Oncologia, Clinica CEHON Rede D'or Oncologia, Salvador, Brazil
³Hematology and Bone Marrow Transplantation UNIT, Rede D'or Oncologia, Salvador, Brazil
⁴Federal University of Bahia, Salvador, Brazil
⁵Hematology, Rede D'or Oncologia- Salvador, Salvador, Brazil
⁶Immunology, molecullar and Cytometry Laboratory- ICS, Federal University of Bahia, Salvador, Brazil
⁷Immunology, mollecular and cytometry Laboratory- ICS, Federal University of Bahia, Salvador, Brazil
⁸Stem Cell Transplant Unit, Federal University of Bahia, Salvador, Brazil
⁹Hematology and Bone Marrow Unit, Rede D´or Oncologia, salvador, Brazil
¹⁰Nuclear Medicin, Rede D'or Oncologia, Salvador, Brazil
¹¹Faculty of Pharmacy, Federal University of Bahia, Salvador, Brazil
¹²Hematology, CLinica CEHON Rede D'or Oncologia, salvador, Brazil
¹³Hematology, Hematology Rede D'or oncologia, salvador, Brazil
¹⁴Immunology, mollecullar and cytometry Laboratory- ICS, Federal University of Bahia, salvador, Brazil
¹⁵Hematology, Clinica CEHON Rede D'or oncologia, Salvador, Brazil
¹⁶Faculty of Phamacy, Federal University of Bahia, salvador, Brazil
¹⁷Department of Hematology, Clinica São Germano and Santa Casa Medical School, São Paulo, Brazil
¹⁸Hematology, Clinica CEHON Rede D'or Oncologia, salvador, Brazil

Peter Duggan, MD, FRCPC¹, Donna E. Reece, MD², Kevin Song, MD³, Victor Jimenez-Zepeda, MD¹, Arleigh McCurdy, MD, BSc⁴, Martha L Louzada, MD, MSc⁵, Hira S Mian, MD⁶, Michael Sebag, MD, PhD⁷, Darrell J White, MD⁸, Julie Stakiw, MD⁹, Richard Leblanc, MD, FRCPC¹⁰, Esther Masih-Khan^2*, Eshetu G Atenafu, M.Sc., P.Stat^11*, Rami Kotb, MD^12*, Muhammad Aslam, MD^13*, Anthony Reiman, MD^14*, Engin Gul, BS, MBA^15* and Christopher P. Venner, MD¹⁶

¹Tom Baker Cancer Center, Department of Hematology, University of Calgary, Calgary, AB, Canada
²Princess Margaret Cancer Centre, Toronto, ON, Canada
³BC Cancer Agency, The University of British Columbia, Vancouver, BC, Canada
⁴Department of Medicine, Division of Hematology, The Ottawa Hospital, Ottawa, ON, Canada
⁵London Health Sciences Centre, London, ON, Canada
⁶Department of Oncology, McMaster University, Hamilton, ON, Canada
⁷Division of Hematology, McGill University Health Centre, Montreal, QC, Canada
⁸Nova Scotia Health Authority, Halifax, NS, Canada
⁹Saskatoon Cancer Centre, Saskatoon, SK, Canada
¹⁰Hôpital Maisonneuve-Rosemont, Université de Montréal, Montreal, QC, Canada
¹¹Princess Margaret Cancer Centre, Department of Biostatistics, University Health Network, University of Toronto, Toronto, ON, Canada
¹²Cancer Care Manitoba, Winnipeg, MB, Canada
¹³Allan Blair Cancer Center, Regina, SK, Canada
¹⁴University of New Brunswick, Saint John Regional Hospital, Saint John, NB, CAN
¹⁵University Health Network-PMH, Vaughan, ON, Canada
¹⁶Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada

Omar Albanyan, MD¹, Samer Alkassis^2*, Seongho Kim, Ph.D^3*, Andrew Kin, MD¹, Asif Alavi, MD¹, Lois Ayash, MD¹, Voravit Ratanatharathorn, MD¹, Dipenkumar Modi, MD¹, Joseph P. Uberti, M.D., Ph.D.¹ and Abhinav Deol, MD¹

¹Department of Oncology, Blood and Marrow Stem Cell Transplant Program, Karmanos Cancer Institute/Wayne State University, Detroit, MI
²Wayne State University, Detroit, MI
³Department of Oncology, Karmanos Cancer Institute/Wayne State University, Detroit, MI

Aimaz Afrough, MD¹, Samer A. Srour, MD, MS², Qaiser Bashir, MD², Neeraj Saini, MD², Chitra Hosing, MD¹, Uday R. Popat, MD², Partow Kebriaei, MD¹, Elizabeth J. Shpall, MD¹, Ruby Delgado^1*, Regan Murphy, PA-C^1*, Elisabet E. Manasanch, MD³, Hans C. Lee, MD³, Gregory P. Kaufman, MD^3*, Krina K. Patel, M.D.⁴, Sheeba K. Thomas, MD³, Donna M. Weber, MD³, Robert Z. Orlowski, MD, PhD⁵, Richard E. Champlin, MD¹ and Muzaffar H. Qazilbash, MD¹

¹Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
²Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX

Iuliana Vaxman, MD, BA^1,2,3*, Alissa Visram, MD^4*, Prashant Kapoor, MD¹, Abdullah S. Al Saleh^5,6*, Shaji K. Kumar, MD¹, Angela Dispenzieri, MD⁷, Francis K. Buadi, MB, CHB^4*, David Dingli, MD, PhD¹, Eli Muchtar, MD^1*, Wilson I Gonsalves, MD⁴, S. Vincent Rajkumar, MD^8*, Taxiarchis Kourelis, MD¹, Rahma M Warsame, MD⁴, Martha Q. Lacy, MD¹ and Morie Gertz¹

¹Mayo Clinic Rochester, Division of Hematology, Rochester, MN
²Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel
³Sackler Schoool of Medicine, Tel Aviv, Israel
⁴Division of Hematology, Mayo Clinic, Rochester, MN
⁵Mayo Clinic, Rochester, Rochester, MN
⁶King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
⁷Mayo Clinic, Rochester, MN
⁸Division of Hematology, Mayo Clinic, Rochester

Yu-Hung Wang, MD^1*, Yi-Kuang Chuang^2*, Yu-Hsuan Yang^2*, Shan-Chi Yu^3*, Yi-Tsung Yang^4*, Bor-Sheng Ko, MD, PhD^5*, Ming Yao, MD^6*, Tai-Chung Huang, MD, PhD^6* and Jih-Luh Tang, M.D., Ph.D.⁵

¹Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan
²Tai Cheng Stem Cell Therapy Center, National Taiwan University Cancer Center, Taipei, Taiwan
³National Taiwan University Hospital, Taipei City, TWN
⁴Division of Hematology-Oncology, Department of Internal Medicine, National Taiwan University Hospital Hsin-Chu Branch, Taipei City, Taiwan
⁵Department of Hematological Oncology, National Taiwan University Cancer Center, Taipei, Taiwan
⁶Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan

Samer A. Srour, MD, MS¹, Qaiser Bashir, MD¹, Denái R. Milton, MS^2*, Yago Nieto, MD³, Rohtesh S. Mehta, MD, MPH, MS¹, Neeraj Saini, MD¹, Ruby Delgado^3*, Gabriela Rondon³, Stefan O. Ciurea, MD³, Uday R. Popat, MD¹, Issa F. Khouri, MD³, Partow Kebriaei, MD³, Elisabet E. Manasanch, MD⁴, Chitra Hosing, MD³, Krina K. Patel, M.D.⁵, Hans C. Lee, MD⁶, Elizabeth J. Shpall, MD³, Robert Z. Orlowski, MD, PhD⁷, Richard E. Champlin, MD³ and Muzaffar H. Qazilbash, MD³

¹Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston, TX
³Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁶Department of Lymphoma and Myeloma, University of Texas M.D. Anderson Cancer Center, Houston, TX
⁷Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX

Samer A. Srour, MD, MS¹, Qaiser Bashir, MD², Denái R. Milton, MS^3*, Yago Nieto, MD¹, Rohtesh S. Mehta, MD, MPH, MS², Neeraj Saini, MD², Ruby Delgado^1*, Gabriela Rondon¹, Chitra Hosing, MD¹, Stefan O. Ciurea, MD¹, May Daher², Uday R. Popat, MD², Issa F. Khouri, MD¹, Partow Kebriaei, MD¹, Elisabet E. Manasanch, MD⁴, Gregory P. Kaufman, MD^4*, Krina K. Patel, M.D.⁵, Elizabeth J. Shpall, MD¹, Hans C. Lee, MD⁴, Robert Z. Orlowski, MD, PhD⁶, Richard E. Champlin, MD¹ and Muzaffar H. Qazilbash, MD¹

¹Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
²Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston, TX
⁴Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁶Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX

Vanessa Fiorini Furtado, MD¹, Dina Brauneis, ANP^2*, Shayna Sarosiek, MD³, Karen Quillen, MD, MPH² and Vaishali Sanchorawala, MD⁴

¹Hematology/Oncology, Boston Medical Center, Boston University, Boston
²Section of Hematology and Oncology, Boston Medical Center, Boston, MA
³Boston University Medical Center, Boston, MA
⁴Section of Hematology and Oncology, Boston Medical Center and Boston University School of Medicine, Boston, MA